{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:26:43Z","timestamp":1779416803920,"version":"3.53.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Blood Cancer United","doi-asserted-by":"publisher","award":["6647-23"],"award-info":[{"award-number":["6647-23"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","award":["LCD-1022356"],"award-info":[{"award-number":["LCD-1022356"]}],"id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA269982"],"award-info":[{"award-number":["R37CA269982"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA196521"],"award-info":[{"award-number":["P30CA196521"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["RSG-24-1188643-01-IBCD"],"award-info":[{"award-number":["RSG-24-1188643-01-IBCD"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI3483"],"award-info":[{"award-number":["CRI3483"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009068","name":"University of Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001287","name":"The Elsa U Pardee Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001068","name":"Dana Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["BC241026P1"],"award-info":[{"award-number":["BC241026P1"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["CA210940"],"award-info":[{"award-number":["CA210940"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xcrm.2026.102753","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:36:43Z","timestamp":1776436603000},"page":"102753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A MICA\/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy models"],"prefix":"10.1016","volume":"7","author":[{"given":"Ruan","family":"Pimenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Taciane da Silva Bortoleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Quasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Ribeiro de Lima Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Marcellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Arriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-2271","authenticated-orcid":false,"given":"Lucas","family":"Ferrari de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102753_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.285.5428.730","article-title":"An activating immunoreceptor complex formed by NKG2D and DAP10","volume":"285","author":"Wu","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102753_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102753_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/85321","article-title":"Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells","volume":"2","author":"Groh","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102753_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2009.07.062","article-title":"An six-amino acid motif in the \u03b13 domain of MICA is the cancer therapeutic target to inhibit shedding","volume":"387","author":"Wang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2026.102753_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1230","article-title":"NKG2D and MICA\/B shedding: a 'tag game' between NK cells and malignant cells","volume":"9","author":"Xing","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","article-title":"Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity","volume":"359","author":"Ferrari de Andrade","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102753_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008987","article-title":"CLN-619, a MICA\/B monoclonal antibody that promotes innate immune cell-mediated antitumor activity","volume":"13","author":"Whalen","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102753_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19420862.2018.1532767","article-title":"High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodies","volume":"11","author":"Lombana","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.xcrm.2026.102753_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00216-020-02409-x","article-title":"Mapping binding epitopes of monoclonal antibodies targeting major histocompatibility complex class I chain-related A (MICA) with hydrogen\/deuterium exchange and electron-transfer dissociation mass spectrometry","volume":"412","author":"Huang","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.xcrm.2026.102753_bib12","doi-asserted-by":"crossref","first-page":"suppl.2588","DOI":"10.1200\/JCO.2024.42.16_suppl.2588","article-title":"Cln-619 (anti-MICA\/B antibody) alone and in combination with pembrolizumab (P) for advanced solid tumors: Updated results of a Ph1 study","volume":"42","author":"Ignacio Melero Bermejo","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102753_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-051116-052433","article-title":"Signaling by Antibodies: Recent Progress","volume":"35","author":"Bournazos","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2008.18.0463","article-title":"Impact of FcgammaRIIa-FcgammaRIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan","volume":"27","author":"Bibeau","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102753_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102753_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2016.4884","article-title":"Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2\/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial","volume":"3","author":"Gavin","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2026.102753_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","article-title":"Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy","volume":"599","author":"Yamin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102753_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-020-2838-z","article-title":"Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection","volume":"588","author":"Bournazos","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102753_bib19","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.ccell.2023.10.007","article-title":"The antitumor activities of anti-CD47 antibodies require Fc-FcgammaR interactions","volume":"41","author":"Osorio","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102753_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.2021011619","article-title":"MICA\/B antibody induces macrophage-mediated immunity against acute myeloid leukemia","volume":"139","author":"Alves da Silva","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102753_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI200422206","article-title":"Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer","volume":"114","author":"Wu","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102753_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of Metastasis by NK Cells","volume":"32","author":"L\u00f3pez-Soto","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102753_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102753_bib24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s43018-020-00125-0","article-title":"A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance","volume":"1","author":"Arriaga","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102753_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2020.00314","article-title":"High-Throughput MICA\/B Genotyping of Over Two Million Samples: Workflow and Allele Frequencies","volume":"11","author":"Klussmeier","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib26","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.1203954109","article-title":"Mouse model recapitulating human Fcgamma receptor structural and functional diversity","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102753_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.532684","article-title":"Improved Detection of in vivo Human NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Using a Novel NOG-FcgammaR-Deficient Human IL-15 Transgenic Mouse","volume":"11","author":"Katano","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102753_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10616-007-9103-2","article-title":"Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies","volume":"55","author":"Mori","year":"2007","journal-title":"Cytotechnology"},{"key":"10.1016\/j.xcrm.2026.102753_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073658","article-title":"Broad MICA\/B expression in the small bowel mucosa: a link between cellular stress and celiac disease","volume":"8","author":"Allegretti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102753_bib30","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41598-018-35736-2","article-title":"A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-beta1 dependent mechanisms","volume":"9","author":"Sharkawy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102753_bib31","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.0508123103","article-title":"Engineered antibody Fc variants with enhanced effector function","volume":"103","author":"Lazar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102753_bib32","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/bloodadvances.2017006866","article-title":"Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma","volume":"1","author":"Casneuf","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2026.102753_bib33","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1158\/1078-0432.CCR-17-3117","article-title":"Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo-Expanded Autologous NK Cells","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102753_bib34","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.immuni.2024.05.021","article-title":"Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity","volume":"57","author":"Delconte","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102753_bib35","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood-2003-01-0019","article-title":"Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia","volume":"102","author":"Salih","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102753_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/bloodadvances.2017015230","article-title":"Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy","volume":"2","author":"Mastaglio","year":"2018","journal-title":"Blood Adv."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:51:29Z","timestamp":1779414689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666379126001709"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102753","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A MICA\/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102753"}}